Tempest Therapeutics Inc (NASDAQ:TPST) price closed higher on Monday, November 20, jumping 9.25% above its previous close.
A look at the daily price movement shows that the last close reads $3.46, with intraday deals fluctuated between $3.31 and $3.93. The company’s 5Y monthly beta was ticking -2.32. Taking into account the 52-week price action we note that the stock hit a 52-week high of $9.77 and 52-week low of $0.17. The stock subtracted -18.88% on its value in the past month.
Tempest Therapeutics Inc, which has a market valuation of $72.76 million, is expected to release its quarterly earnings report Nov 08, 2023. Analysts tracking TPST have forecast the quarterly EPS to shrink by -0.39 per share this quarter, while the same analysts predict the annual EPS to hit -$1.93 for the year 2023 and up to -$1.29 for 2024. In this case, analysts estimate an annual EPS growth of 37.50% for the year and 33.20% for the next year.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with 1 upward and no downward reviews. On the technical perspective front, indicators give TPST a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that TPST’s price is at present 2.84% off the SMA20 and 45.60% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 53.59, with weekly volatility standing at 12.68%. The indicator jumps to 17.42% when calculated based on the past 30 days. Tempest Therapeutics Inc (NASDAQ:TPST)’s beta value is holding at -1.27, while the average true range (ATR) indicator is currently reading 0.78. Considering analysts have assigned the stock a price target range of $8.00-$47.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $21.67. Based on this estimate, we see that current price is roughly -111.64% off the estimated low and -1143.39% off the forecast high. Investors will no doubt be excited to see the share price fall to $10.00, which is the median consensus price, and at that level TPST would be -164.55% from current price.
An analysis of the Tempest Therapeutics Inc (NASDAQ:TPST) stock in terms of its daily trading volume indicates that the 3-month average is 10.25 million. However, this figure increases on the past 10-day timeline to an average of 7.73 million.
Current records show that the company has 19.25M in outstanding shares. The insiders’ percentage holdings are 42.56% of outstanding shares while the percentage share held by institutions stands at 14.23%. The stats also highlight that short interest as of Oct 30, 2023, stood at 1.4 million shares, which puts the short ratio at the time at 0.05. From this we can glean that short interest is 10.51% of company’s current outstanding shares. Notably, we see that shares short in October rose slightly given the previous month’s figure stood at 29970.0. But the 228.70% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.